Original Article
The Enhancing Secondary Prevention in Coronary Artery Disease trial
Finlay A McAlister, Miriam Fradette, Sumit R Majumdar, Randall Williams, Michelle Graham, James McMeekin, William A Ghali, Ross T Tsuyuki and Jeremy Grimshaw
CMAJ November 23, 2009 DOI: https://doi.org/10.1503/cmaj.090917
Finlay A McAlister
Miriam Fradette
Sumit R Majumdar
Randall Williams
Michelle Graham
James McMeekin
William A Ghali
Ross T Tsuyuki
This is a PDF-only article.
In this issue
Article tools
The Enhancing Secondary Prevention in Coronary Artery Disease trial
Finlay A McAlister, Miriam Fradette, Sumit R Majumdar, Randall Williams, Michelle Graham, James McMeekin, William A Ghali, Ross T Tsuyuki, Jeremy Grimshaw
CMAJ Nov 2009, DOI: 10.1503/cmaj.090917
Jump to section
Related Articles
Cited By...
- Enhancing prescribing of guideline-recommended medications for ischaemic heart diseases: a systematic review and meta-analysis of interventions targeted at healthcare professionals
- Association between in-hospital guideline adherence and postdischarge major adverse outcomes of patients with acute coronary syndrome in Vietnam: a prospective cohort study
- Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial
- A Cluster Randomized Trial of an Enhanced eGFR Prompt in Chronic Kidney Disease
- Why didn't it work?